Statins in the 21st century: end of the simple story? (Q34481748)

2 August 2017

1 reference

title

Statins in the 21st century: end of the simple story? (English)

1 reference

2 August 2017

Doggrell SA

1

1 reference

PubMed ID

11772284

2 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

9

1 reference

2 August 2017

1755-1766

1 reference

The evolving role of statins in the management of atherosclerosis

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

The pravastatin inflammation CRP evaluation (PRINCE): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

Pravastatin Therapy and the Risk of Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1755

10.1517/13543784.10.9.1755

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11772284